Literature DB >> 8822983

Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients.

S Taddei1, A Virdis, P Mattei, L Ghiadoni, I Sudano, A Salvetti.   

Abstract

BACKGROUND: Essential hypertension is characterized by impaired endothelium-dependent vasodilation. The present study was designed to investigate whether this abnormality is a primary defect or a consequence of blood pressure increases. METHODS AND
RESULTS: In offspring of essential hypertensive patients (n = 34) and normotensive subjects (n = 30), we evaluated forearm blood flow (strain-gauge plethysmography) modifications induced by intrabrachial acetylcholine (0.15, 0.45, 1.5, 4.5, and 15 micrograms.100 mL-1.min-1), an endothelium-dependent vasodilator, and sodium nitroprusside (1, 2, and 4 micrograms.100 mL-1.min-1), an endothelium-independent vasodilator. Minimal forearm vascular resistances also were calculated as the ratio between mean intra-arterial pressure and maximal forearm blood flow induced by forearm ischemia and hand exercise. Vasodilation to acetylcholine was significantly (P < .01) blunted in offspring of hypertensive patients compared with offspring of normotensive subjects, whereas the responses to sodium nitroprusside and minimal forearm vascular resistances were similar. In two subgroups of 14 offspring of essential hypertensive patients but not in 10 offspring of normotensive subjects, vasodilation to acetylcholine was increased by intra-brachial L-arginine (1 mumol.100 mL-1.min-1), the substrate for nitric oxide synthesis, whereas in the other 10 and 8 offspring of essential hypertensive patients and normotensive subjects, respectively, cyclooxygenase blockade by intra-brachial indomethacin (50 micrograms.100 mL-1.min-1) was ineffective.
CONCLUSIONS: Offspring of essential hypertensive patients are characterized by a reduced response to acetylcholine linked to a defect in the nitric oxide pathway, suggesting that an impairment in nitric oxide production precedes the onset of essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822983     DOI: 10.1161/01.cir.94.6.1298

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  59 in total

Review 1.  Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links.

Authors:  R D Rudic; W C Sessa
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

2.  Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility.

Authors:  Melissa A H Witman; Ryan S Garten; Jayson R Gifford; H Jonathan Groot; Joel D Trinity; Josef Stehlik; Jose N Nativi; Craig H Selzman; Stavros G Drakos; Russell S Richardson
Journal:  JACC Heart Fail       Date:  2015-08-12       Impact factor: 12.035

Review 3.  Adventures in vascular biology: a tale of two mediators.

Authors:  S Moncada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-05-29       Impact factor: 6.237

Review 4.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

5.  Fumarase Overexpression Abolishes Hypertension Attributable to endothelial NO synthase Haploinsufficiency in Dahl Salt-Sensitive Rats.

Authors:  Hong Xue; Aron M Geurts; Kristie Usa; Feng Wang; Yingying Lin; Jenifer Phillips; Lisa Henderson; Maria Angeles Baker; Zhongmin Tian; Mingyu Liang
Journal:  Hypertension       Date:  2019-06-24       Impact factor: 10.190

6.  AHA/ACC-defined stage 1 hypertensive adults do not display cutaneous microvascular endothelial dysfunction.

Authors:  Gabrielle A Dillon; Jody L Greaney; Sean Shank; Urs A Leuenberger; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-31       Impact factor: 4.733

7.  The ocular hemodynamic response to nitric oxide synthase inhibition is unaltered in patients with early type I diabetes.

Authors:  Guido T Dorner; Gerhard Garhöfer; Nicole Selenko; Peter Fasching; Michaela Bayerle-Eder; Leopold Schmetterer; Michael Wolzt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-06-26       Impact factor: 3.117

Review 8.  Endothelial nitric oxide synthase polymorphisms and hypertension.

Authors:  Aroon D Hingorani
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 9.  The L-arginine-nitric oxide pathway in hypertension.

Authors:  Malte Kelm
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 10.  Alzheimer's disease and endothelial dysfunction.

Authors:  Giuseppe Bomboi; Lorenzo Castello; Francesco Cosentino; Franco Giubilei; Francesco Orzi; Massimo Volpe
Journal:  Neurol Sci       Date:  2009-10-17       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.